Akero Therapeutics, Inc. (AKRO) SEC filings
AKRO SEC filings moved a median of -0.09% by the close. AKRO SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the AKRO overview →
44 measured AKRO SEC filing events.
Where these AKRO SEC filings landedvs 40 measured AKRO SEC filing reactions
| Middle 50% of AKRO SEC filing reactions | -2.25% to +1.40% |
|---|---|
| Median reaction (to close) | -0.09% |
| Measured reactions | 40 |
Point-in-time · zero look-ahead
Half of the 40 AKRO SEC filing events with a measured close landed between -2.25% and +1.40%; 48% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G Akero Therapeutics, Inc. | SEC filing · Form 15-12G | — | — | |
| Form 8-K Akero Therapeutics, Inc. For: Dec 09 | SEC filing · Form 8-K | — | — | |
| Form POSASR Akero Therapeutics, Inc. | SEC filing · Form POSASR | — | — | |
| Form S-8 POS Akero Therapeutics, Inc. | SEC filing · Form S-8 | — | — | |
| Form 8-K Akero Therapeutics, Inc. For: Dec 02 | SEC filing · Form 8-K | +0.02% | +0.06% | |
| Form DEFA14A Akero Therapeutics, Inc. | SEC filing · Form DEFA14A | +0.08% | +0.06% | |
| Form 10-Q Akero Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.08% | +0.09% | |
| Form DEFM14A Akero Therapeutics, Inc. | SEC filing · Form DEFM14A | +0.00% | +0.07% | |
| Form PREM14A Akero Therapeutics, Inc. For: Oct 24 | SEC filing · Form PREM14A | -0.03% | -0.08% | |
| Form 8-K Akero Therapeutics, Inc. For: Oct 08 | SEC filing · Form 8-K | -0.03% | -0.37% | |
| Form DEFA14A Akero Therapeutics, Inc. | SEC filing · Form DEFA14A | -0.03% | -0.37% | |
| Form 8-K Akero Therapeutics, Inc. For: Sep 23 | SEC filing · Form 8-K | +0.44% | -0.71% | |
| Form 10-Q Akero Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.41% | +1.41% | |
| Form 8-K Akero Therapeutics, Inc. For: Aug 08 | SEC filing · Form 8-K | +1.41% | +1.41% | |
| Form 8-K Akero Therapeutics, Inc. For: Jun 03 | SEC filing · Form 8-K | -0.07% | +2.14% | |
| Form 10-Q Akero Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.90% | +3.57% | |
| Form 8-K Akero Therapeutics, Inc. For: May 12 | SEC filing · Form 8-K | +2.90% | +3.57% | |
| Form ARS Akero Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +0.48% | +1.98% | |
| Form DEF 14A Akero Therapeutics, Inc. For: Apr 26 | SEC filing · Form DEF | +0.48% | +1.98% | |
| Form 10-K Akero Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -4.83% | +0.94% | |
| Form 8-K Akero Therapeutics, Inc. For: Feb 28 | SEC filing · Form 8-K | -4.83% | +0.94% | |
| Form S-8 Akero Therapeutics, Inc. | SEC filing · Form S-8 | +0.93% | -5.30% | |
| Form 8-K Akero Therapeutics, Inc. For: Jan 28 | SEC filing · Form 8-K | -0.54% | -0.68% | |
| Form 8-K Akero Therapeutics, Inc. For: Jan 27 | SEC filing · Form 8-K | -2.66% | -9.33% | |
| Form 10-Q Akero Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.04% | -0.81% | |
| Form 8-K Akero Therapeutics, Inc. For: Nov 08 | SEC filing · Form 8-K | -2.04% | -0.81% | |
| Form 10-Q Akero Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.29% | -2.25% | |
| Form 8-K Akero Therapeutics, Inc. For: Aug 09 | SEC filing · Form 8-K | -2.29% | -2.25% | |
| Form 8-K Akero Therapeutics, Inc. For: Jun 07 | SEC filing · Form 8-K | -0.80% | +1.40% | |
| Form 10-Q Akero Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.98% | -7.96% | |
| Form 8-K Akero Therapeutics, Inc. For: May 10 | SEC filing · Form 8-K | -0.98% | -7.96% | |
| Form S-3ASR Akero Therapeutics, Inc. | SEC filing · Form S-3ASR | +2.14% | +4.88% | |
| Form ARS Akero Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +0.26% | -0.10% | |
| Form DEF 14A Akero Therapeutics, Inc. For: Jun 07 | SEC filing · Form DEF | +0.26% | -0.10% | |
| Form PRE 14A Akero Therapeutics, Inc. For: Jun 07 | SEC filing · Form PRE | -0.63% | -2.22% | |
| Form 8-K Akero Therapeutics, Inc. For: Mar 12 | SEC filing · Form 8-K | +1.25% | -3.18% | |
| Form 8-K Akero Therapeutics, Inc. For: Mar 05 | SEC filing · Form 8-K | +2.23% | +1.51% | |
| Form 8-K Akero Therapeutics, Inc. For: Mar 04 | SEC filing · Form 8-K | +1.58% | -12.45% | |
| Form 10-K Akero Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +3.35% | -3.71% | |
| Form 8-K Akero Therapeutics, Inc. For: Feb 29 | SEC filing · Form 8-K | +3.35% | -3.71% | |
| Form S-8 Akero Therapeutics, Inc. | SEC filing · Form S-8 | +5.58% | +1.50% | |
| Form 8-K Akero Therapeutics, Inc. For: Dec 18 | SEC filing · Form 8-K | -1.36% | -3.17% | |
| Form 10-Q Akero Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.57% | +0.42% | |
| Form 8-K Akero Therapeutics, Inc. For: Nov 13 | SEC filing · Form 8-K | -0.57% | +0.42% |
Keep exploring
More AKRO: earnings → · analyst actions → · AKRO overview →